Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-κBp50
Mary Canavan,Ciara McCarthy,Nadia Ben Larbi,Jennifer K Dowling,Laura Collins,Finbarr O’Sullivan,Grainne Hurley,Carola Murphy,Aoife Quinlan,Gerry Moloney,Trevor Darby,John MacSharry,Hiroyuki Kagechika,Paul Moynagh,Silvia Melgar,Christine E Loscher
DOI: https://doi.org/10.1177/1753425913501915
2013-09-17
Innate Immunity
Abstract:There is now convincing evidence that liver X receptor (LXR) is an important modulator of the inflammatory response; however, its mechanism of action remains unclear. This study aimed to examine the effect of LXR on the IL-12 family of cytokines and examined the mechanism by which LXR exerted this effect. We first demonstrated that activation of murine-derived dendritic cells (DC) with a specific agonist to LXR enhanced expression of LXR following activation with LPS, suggesting a role in inflammation. Furthermore, we showed LXR expression to be increased in vivo in dextrane sulphate sodium-induced colitis. LXR activation also suppressed production of IL-12p40, IL-12p70, IL-27 and IL-23 in murine-derived DC following stimulation with LPS, and specifically targeted the p35, p40 and EBI3 subunits of the IL-12 cytokine family, which are under the control of the NF-κB subunit p50 (NF-κBp50). Finally, we demonstrated that LXR can associate with NF-κBp50 in DC and that LXR activation prevents translocation of the p50 subunit into the nucleus. In summary, our study indicates that LXR can specifically suppress the IL-12 family of cytokines though its association with NF-κBp50 and highlights its potential as a therapeutic target for chronic inflammatory diseases.
microbiology,biochemistry & molecular biology,immunology,medicine, research & experimental